Meyer, S, Bay, J, Franz, AR, Ehrhardt, H, Klein, L, Petzinger, J, Binder, C, Kirschenhofer, S, Stein, A, Hüning, B, Heep, A, Cloppenburg, E, Muyimbwa, J, Ott, T, Sandkötter, J, Teig, N, Wiegand, S, Schroth, M, Kick, A, Wurm, D, Gebauer, C, Linnemann, K, Kittel, J, Wieg, C, Kiechl-Kohlendorfer, U, Schmidt, S, Böttger, R, Thomas, W, Brevis Nunez, F, Stockmann, A, Kriebel, T, Müller, A, Klotz, D, Morhart, P, Nohr, D, Biesalski, HK, Giannopoulou, EZ, Hilt, S, Poryo, M, Wagenpfeil, S, Haiden, N, Ruckes, C, Ehrlich, A, Gortner, L & NeoVitaA trial investigators 2024, '
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial',
The Lancet Respiratory Medicine, vol. 12, no. 7, pp. 544-555.
https://doi.org/10.1016/S2213-2600(24)00073-0